Vapotherm invented HFNC and now sells an advanced form of HFNC that provides high flow at a high velocity, rapidly flushing the dead space in the limited time between breaths when respiratory rates ...
Children, as well as their parents, may one day be able to breathe a little easier: The respiratory therapy company Vapotherm said a pilot study of its high-flow treatment showed it could outperform ...
EXETER, N.H., Feb. 29, 2024 /PRNewswire/ -- Vapotherm, Inc. (OTCQX: VAPO), ("Vapotherm" or the "Company"), a global medical technology company specializing in the development and commercialization of ...
EXETER, N.H., May 20, 2025 /PRNewswire/ -- Vapotherm, Inc., the global leader in mask-free noninvasive respiratory support, is proud to announce the publication of a new clinical study, Effect of ...
Infinium Medical, through its Infinium Veterinary division will be exclusively distributing Vapotherm VET 2.0 high-velocity respiratory therapy systems. This partnership allows us to provide ...
Respiratory care specialist Vapotherm raised $56 million in an initial public offering of 4 million shares, priced at the low end of the range at $14. The Exeter, New Hampshire-based company plans to ...
Vapotherm to Expand Production Capacity in Advance of Potential Increase in Demand for High-Flow Nasal Cannula Systems for Treating COVID-19 Respiratory Distress Increased capacity anticipated to ...
Increased capacity anticipated to scale capital production by up to 20X above pre-COVID-19 pandemic levels At maximum capacity, increased production could create up to 350 manufacturing jobs in New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results